Is a 5.4 A1C Considered Prediabetes?

An A1C of 5.4% falls below the threshold for prediabetes. The American Diabetes Association defines prediabetes as an A1C between 5.7% and 6.4%, with anything at or above 6.5% qualifying as diabetes. By that standard, 5.4% is squarely in the normal range. But that clean cutoff obscures real complexity underneath it, from natural test variability to conditions that can skew the result, to the fact that metabolic risk does not magically start at 5.7%.

Where the Cutoffs Come From

The 5.7% lower boundary for prediabetes was chosen by the American Diabetes Association based on the point at which the risk of progressing to full type 2 diabetes begins to rise meaningfully. It is not an international consensus, though. The International Expert Committee and the World Health Organization use a higher entry point of 6.0% for their equivalent “at-risk” category. That discrepancy matters: a cohort study found that when the threshold was set at 5.7%, about 56% of participants were classified as high-risk, but when it was raised to 6.0%, that proportion dropped to 22%.¹ That is a huge swing based on a fraction of a percentage point, which should tell you something about how arbitrary the boundary is.

At the 5.7% ADA threshold, the five-year risk of developing type 2 diabetes was about 7%, compared to roughly 15% at the 6.0% IEC threshold. People at the top of the prediabetes range (6.2–6.4%) had a five-year risk closer to 26%, while those at 5.7–5.9% had a risk of only about 2%.¹ The practical takeaway: someone at 5.4% has a lower short-term risk than someone at 5.8%, even though both technically fall outside the prediabetes label under ADA rules. The categories are useful for public health screening, but they are not magic lines drawn by biology.

Why Your 5.4% May Not Be Exactly 5.4%

A1C is often treated as a precise number, but it has some wobble built into it. Part of that comes from the lab instrument, and part comes from your own biology. A systematic review and meta-analysis of within-person A1C variation found that in healthy people, the coefficient of variation was around 1.7%, while in people with type 2 diabetes it was closer to 8.3%.² For someone without diabetes, a reading of 5.4% could realistically reflect a true value anywhere in a narrow band around that number. An independent analysis using biological variation data from a large reference database pegged the within-person biological variation for A1C at about 1.8%.³

What this means practically: if you had your blood drawn today and again next month under the same conditions, the two results would probably be close, but not necessarily identical. A reading of 5.4% today could come back as 5.3% or 5.5% on a retest. This is not a failure of the test; it is just how biological measurement works. It does, however, mean that a single A1C value right near a diagnostic boundary should be interpreted cautiously, and that your 5.4% is comfortably below the prediabetes cutoff rather than teetering on its edge.

Conditions That Distort A1C Readings

A1C measures the percentage of hemoglobin in your red blood cells that has glucose stuck to it. Anything that changes the lifespan of your red blood cells or alters your hemoglobin itself can throw the number off, sometimes by a clinically meaningful amount. A 5.4% that looks reassuring might actually underestimate your true glucose exposure, or in rarer cases, overestimate it.

Iron Deficiency Anemia

Iron deficiency is one of the more common reasons an A1C might read artificially high. A study comparing anemic patients to healthy controls found that the mean baseline A1C in the anemic group was 4.6%, compared to 5.5% in the control group. After iron treatment, A1C rose significantly in the anemic patients.⁴ The mechanism involves changes to red blood cell turnover: when iron is low, older red blood cells accumulate more glycation, which can push A1C upward. If you have untreated iron deficiency, your 5.4% might be an inflated reading that would drop once the anemia is corrected. Conversely, if you recently started iron supplementation and your red blood cell production surged, the A1C could temporarily read lower than your actual glucose control.

Hemoglobin Variants

Structural variants of hemoglobin, including sickle cell trait, hemoglobin C, hemoglobin E, and others, can interfere with A1C measurement. The direction and size of the error depend on which variant you carry and which lab method is used to analyze the sample.⁵ Some methods will read artificially low in people with sickle cell trait; others read high. Case reports have documented situations where a hemoglobin variant produced an A1C so far off the mark that it was clinically misleading.⁶ A study comparing three different A1C testing platforms in people with sickle cell trait found significant differences between systems, with one tending to give lower results and another higher.⁷ If you carry a hemoglobin variant and have never discussed it with your doctor, your A1C results may not accurately reflect your average blood sugar.

Pregnancy

During pregnancy, the body’s physiology shifts in ways that make A1C less reliable. Research from Massachusetts General Hospital found that between the first trimester and late second trimester, actual glucose levels (measured by oral glucose tolerance testing) rose by about 8 mg/dL, while A1C simultaneously dropped by 0.13%. By the late second trimester, glucose was roughly 13 mg/dL higher than what the A1C would have predicted. Lower hemoglobin levels were associated with a bigger gap between the two measures. If you are pregnant and your A1C reads 5.4%, your actual glucose exposure may be somewhat higher than that number suggests.

Age and Ethnicity Shift the Baseline

Even in people with perfectly normal glucose metabolism, A1C drifts upward with age. An analysis using data from the Framingham Offspring Study and the National Health and Nutrition Examination Survey found that every additional year of age was associated with roughly a 0.01-percentage-point increase in A1C, even after excluding people with impaired fasting glucose or impaired glucose tolerance.⁸ That may sound tiny, but it adds up: a healthy 25-year-old and a healthy 65-year-old can differ by roughly 0.4 percentage points in A1C without any difference in their glucose control. A separate large NHANES analysis spanning 15 years confirmed the pattern, finding A1C rose by about 0.008–0.009% per year in people with no detectable glucose abnormality.⁹

A 5.4% reading therefore means something slightly different at age 30 than at age 70, even though both are “normal” on the lab report.

Race and ethnicity also play a role. In the Diabetes Prevention Program, among participants who all had the same degree of impaired glucose tolerance, average A1C was 5.78% for white participants, 5.93% for Hispanic participants, 6.00% for Asian participants, 6.12% for American Indian participants, and 6.18% for Black participants, after adjusting for age, sex, BMI, fasting glucose, and insulin resistance.¹⁰ These differences persisted even after accounting for measured differences in glucose handling, which means they likely reflect non-glycemic factors such as red blood cell lifespan or hemoglobin glycation rates. A 5.4% in a Black individual may correspond to a different average blood sugar than a 5.4% in a white individual. This has real implications for how clinicians should interpret results near the diagnostic boundaries, though there is no consensus yet on using race-adjusted thresholds.

Below Prediabetes Does Not Mean Zero Risk

The diagnostic label “prediabetes” starts at 5.7%, but metabolic risk is a continuum, not a light switch. A large Canadian population study of more than 600,000 adults without diabetes found that men with an A1C of 5.5–5.9% already had a 12% higher risk of cardiovascular disease hospitalization compared to those at 5.0–5.4%.¹¹ For women, that particular bump was not statistically significant, but at higher A1C levels both sexes showed clearly elevated risk. The researchers specifically noted that the association between cardiovascular disease and A1C levels considered “normal” highlights the importance of addressing cardiac risk factors at all levels of glycemia.

Data from the Atherosclerosis Risk in Communities study told a similar story for heart failure. After adjusting for other risk factors including fasting glucose, people with an A1C between 5.5% and 6.0% had a 16% higher hazard of developing heart failure compared to those below 5.5%.¹² These findings suggest that even before glucose levels reach the prediabetes threshold, chronically elevated blood sugar may contribute to cardiovascular damage.

Where does 5.4% fall in this picture? It sits at the upper edge of the reference group that these studies used as their comparison baseline (5.0–5.4%). You are not yet in the range where elevated risk has been convincingly demonstrated. But if your A1C has been trending upward over time, say from 5.1% three years ago to 5.4% today, that trajectory warrants attention even though neither number qualifies as prediabetic.

From the diabetes-progression side, the European Prospective Investigation of Cancer-Norfolk cohort study found that people with a baseline A1C of 6.0–6.4% had a fifteen-fold higher incidence of developing diabetes compared to those below 5.0%.¹³ The risk gradient was steep but not binary: it started climbing well before the official prediabetes zone, reinforcing the notion that glucose metabolism sits on a spectrum.

When A1C and Fasting Glucose Tell Different Stories

One thing that catches people off guard is that you can have a normal A1C but an elevated fasting glucose, or the reverse. These two tests measure different things: A1C reflects roughly three months of average blood sugar, while fasting glucose is a snapshot of what your blood sugar is doing first thing in the morning. They often agree, but not always.

A study in a Malaysian cohort found that 10.6% of participants had prediabetes according to fasting glucose, but 14.2% had prediabetes according to A1C. The agreement between the two tests was moderate at best.¹⁴ Another study looking at discordance between the tests found even wider gaps: among people classified as prediabetic by A1C, only about 20% received the same classification from fasting glucose.¹⁵

So if your A1C is 5.4% but your fasting glucose is, say, 105 mg/dL (which would fall in the impaired fasting glucose range of 100–125), you could have early glucose dysregulation that the A1C is not capturing yet. This kind of discordance is why clinicians sometimes use both tests together rather than relying on either one alone, and why a single A1C of 5.4% does not automatically give your metabolic health a clean bill.

Alternative Markers When A1C Is Not Trustworthy

For people whose A1C may be unreliable due to hemoglobin variants, anemia, kidney disease, or recent blood transfusions, alternative blood sugar markers exist. Fructosamine and glycated albumin both measure how much glucose has attached to proteins in the blood, but they reflect a shorter window, roughly two to three weeks, rather than A1C’s two-to-three-month average.¹⁶ These markers are unaffected by hemoglobin variants or red blood cell lifespan, which makes them useful in the specific situations where A1C falls short.¹⁷

Continuous glucose monitors have also entered the conversation, though their role in people without diabetes is still evolving. A recent study looking at people with prediabetes and normal glucose levels found that standard CGM metrics like mean glucose and time in range did not correlate well with A1C in this population.¹⁸ The researchers concluded that CGM data should not be used as a proxy for A1C in people who do not have diabetes. That does not mean CGMs are useless in this group; they can still reveal post-meal glucose spikes that neither A1C nor fasting glucose would catch. But interpreting their output requires different expectations than in someone with established diabetes.

Medications and Supplements That Nudge A1C

Some drugs can shift your A1C reading without changing your actual blood sugar. High doses of vitamins C and E have been reported to lower A1C by interfering with the glycation process itself, though the evidence is mixed on whether standard supplementation doses produce a meaningful effect. Chronic aspirin use has been reported to falsely decrease A1C through a similar mechanism.¹⁹ Any drug that affects red blood cell production or destruction, including erythropoietin and certain HIV medications, can also shift A1C in either direction.

If you take any of these and your A1C comes back at 5.4%, the result might be slightly lower than your true average glucose. Conversely, if you are on a medication that prolongs red blood cell lifespan, your A1C might read a touch higher than it should. These effects are usually small, but they are worth mentioning to your doctor, especially if your result is near a diagnostic cutoff.

What A1C Actually Translates to in Blood Sugar Terms

A1C is reported as a percentage, which is not intuitive for most people. The A1C-Derived Average Glucose study established a reliable conversion. The relationship between A1C and average blood glucose is linear: the formula works out so that each 1-percentage-point increase in A1C corresponds to roughly a 29 mg/dL increase in average glucose.²⁰ For an A1C of 5.4%, that translates to an estimated average glucose of about 108 mg/dL. For context, the prediabetes threshold of 5.7% corresponds to roughly 117 mg/dL, and the diabetes threshold of 6.5% corresponds to about 140 mg/dL.

These are averages, not minute-by-minute readings. Your blood sugar swings above and below this number throughout the day, and two people with identical A1C levels can have very different daily glucose patterns. One might cruise along steadily near 108 while the other spikes to 160 after meals and drops to 75 between them. A1C cannot tell you which pattern you have, which is part of why some clinicians find value in pairing it with fasting glucose or occasional post-meal testing.

The Trend Line Matters More Than Any Single Result

A single A1C of 5.4% is a data point. A series of A1C results over years is a story. If your A1C was 5.0% five years ago, 5.2% three years ago, and 5.4% today, you are watching a steady upward drift. At a rate of about 0.1% per year, you would cross the prediabetes threshold of 5.7% within a few years if nothing changes. That trajectory is actionable even though no single reading is abnormal.

On the other hand, if your A1C has held steady at 5.3–5.4% for a decade, that consistency is itself meaningful and reassuring. The absolute number matters less than whether it is moving. Most primary care physicians will order A1C annually or every few years for adults with risk factors, which gives you enough data points to spot a trend. If you do not have risk factors and your A1C is 5.4%, the result is genuinely good news, but it is still worth watching over time rather than filing away and forgetting.